logo

DoD Autism, Idea Development Award

Sector: Hospital • Location: United States of America

Source: Grants.gov

Project
Archived

The ARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with ASD. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation. The FY20 ARP Idea De

Project Information FAQ

Project Information

5 Q
The project “DoD Autism, Idea Development Award” is an infrastructure initiative in the Hospital sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

archived

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

The ARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with ASD. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation. The FY20 ARP Idea Development Award seeks applications from all areas of research. The ARP encourages applications that address the critical needs of the ASD community in one or more of the following areas: • Tests of implementation strategies to increase use of evidence-based practices • Development of healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the life span and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief) • Assessment of novel therapeutics using valid preclinical models • Mechanisms of heterogeneous clinical expression of ASD • Environmental risk factors • Improve diagnosis across the life span • Factors promoting success in key transitions to independence for individuals living with ASD • Cultural and socioeconomic factors in treatment efficacy, delivery, and access to services • Mechanisms underlying sex differences in ASD diagnosis • Mechanisms underlying conditions co-occurring with ASD (e.g., sleep disturbances, gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit, seizures) • Factors impacting quality of life during geographic relocation, such as military permanent change of station • Long-term treatment outcomes from previous clinical trials for ASD core symptoms or to alleviate co-occurring conditions

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data